Complications of Prosthetic Valves

Slide 1 · Complications of prosthetic heart valves

Morphologic mechanisms, clinical consequences, and interpretive pathways

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Differentiate mechanical from tissue valve design and failure patterns.

Explain how abnormal flow causes mechanical-valve thrombosis and why anticoagulation adds bleeding risk.

Relate tissue-valve degeneration and prosthetic infection to structural dysfunction.

Distinguish leaks, obstruction, orifice disproportion, and hemolysis using mechanisms.

Slide 3 · Valve dysfunction has two fundamental expressions

Pathologic expression

What changes

Expected burden

Stenosis

Effective valve opening is reduced

Pressure overload upstream of the valve

Regurgitation

Closure fails; blood leaks backward

Volume overload involving the affected chambers

Both

Obstruction and incompetence coexist

Combined hemodynamic burden

Slide 4 · Prostheses improve prognosis but are not native valves

Diseased native valve

Existing stenosis and/or regurgitation

Valve replacement

Substitute restores a route for flow

Non-native material

Interface, geometry, and tissue differ

Potential complications

Thrombosis, degeneration, infection, or leak

SCHEMATIC — causal / functional relationships

The major prognostic benefit of replacement despite device-specific failure modes.

Slide 5 · Two major categories of replacement valves

Characteristic

Mechanical valve

Tissue valve (bioprosthesis)

Primary material

Rigid, nonphysiologic materials

Human cadaveric or animal leaflet tissue

Typical architecture

Hinged semicircular flaps; bileaflet tilting disks

Flexible leaflets mounted on a frame

Major long-term liability

Thrombosis and anticoagulation-related bleeding

Calcification and/or tearing

Slide 6 · Mechanical valves: Rigid bileaflet architecture

Conceptual schematic — bileaflet mechanical device

Rigid components

Nonphysiologic material

Hinged flaps

Semicircular opening elements

Bileaflet motion

Permits forward flow

Nonlaminar flow

Turbulence and local stasis

Slide 7 · Bioprostheses: Flexible nonviable leaflets

Human or animal tissue

Cryopreserved cadaveric or devascularized animal tissue

Frame-supported cusps

Flexible leaflets mounted on a prosthesis

Native-like movement

Function more closely resembles a natural valve

Late deterioration

Calcification or tearing limits durability

SCHEMATIC — causal / functional relationships

Slide 8 · Bioprostheses can be deployed by catheter

Diseased native annulus

Original valve location

Catheter-based delivery

Implant without conventional open valve surgery

Bioprosthetic deployment

Valve is positioned within original annulus

Example

Transcatheter aortic valve replacement

SCHEMATIC — causal / functional relationships

Increasing catheter-based use, especially where open surgery is unsuitable.

Slide 9 · Valve design implies a different dominant trade-off

Dimension

Mechanical

Bioprosthetic

Durability of structure

Structural deterioration is rare with current devices

Long-term cusp calcification and/or tearing

Thrombotic liability

Major consideration

Not characterized as dominant in this section

Chronic anticoagulation

Required because of mechanical-valve thrombotic risk

No universal regimen specified by this source

Endocarditis

Potential complication

Potential complication

Slide 10 · A prosthesis can fail without a fractured component

Functional failure

Possible pathology

Underlying problem

Obstruction

Thrombus; fibrous overgrowth; small effective orifice

Forward flow restricted

Regurgitation

Paravalvular leak; degenerated tissue leaflet

Backward blood flow

Systemic complication

Embolization; infection; bleeding; hemolysis

Damage beyond the valve itself

Slide 11 · Ten-year burden: A substantial cumulative problem

≈60%

Within 10 years

That approximately 60% of valve recipients develop a serious prosthesis-related problem within 10 years after surgery.

This is a composite statement about serious prosthesis-related problems—not a rate for any one specific mechanism.

Risk differs by valve type; Do not interpret the figure as a head-to-head comparison of devices.

Slide 12 · Taxonomy: Four major mechanisms plus related effects

Flow-related

Thrombus and embolization

Material-related

Bioprosthetic degeneration

Infectious

Prosthetic endocarditis

Interface / geometry

Leak, tissue overgrowth, mismatch, shear

SCHEMATIC — causal / functional relationships

Slide 13 · Mechanical-valve thromboembolism starts with flow

Mechanical flow geometry

Not fully physiologic

Nonlaminar blood flow

Turbulent regions plus zones of stasis

Thrombus formation

Blood deposits on or near prosthesis

Two consequences

Device occlusion or detached embolus

SCHEMATIC — causal / functional relationships

Slide 14 · Why nonlaminar flow matters

Nonlaminar flow as a property of mechanical devices.

A prosthesis creates focal regions of turbulence and stasis instead of uniformly streamlined flow.

Those flow disturbances favor local thrombus formation.

The resulting mass can remain at the valve or become a source of emboli.

Nonlaminar flow → thrombogenic conditions

Slide 15 · Turbulence: Disturbed flow near a rigid prosthesis

Rigid moving elements

Bileaflet mechanical structure

Disturbed streamlines

Turbulence develops

Nonuniform local conditions

Prothrombotic flow environment

Clinical hazard

Thrombus at the prosthesis

SCHEMATIC — causal / functional relationships

Slide 16 · Stasis: Slower-flow regions add thrombotic risk

Complex prosthetic geometry

Mechanical components and hinges

Focal slow-flow regions

Local stasis

Blood stagnation

Promotes thrombus formation

Thrombotic burden

May compromise valve performance

SCHEMATIC — causal / functional relationships

Slide 17 · Turbulence and stasis act as paired contributors

Flow disturbance

Prosthetic setting

Consequential risk

Turbulence

Nonlaminar flow around a mechanical device

Thrombus formation

Stasis

Local slow-flow foci within disturbed circulation

Thrombus formation

Combined exposure

Both present in the same device

Thrombotic occlusion or embolization

Slide 18 · Two clinically distinct thrombotic outcomes

Outcome

Event at valve

Consequence

Prosthetic thrombosis

Thrombus occludes the valve orifice

Reduced forward flow; functional obstruction

Thromboembolism

Thrombus forms at valve then detaches

Embolus travels beyond original thrombus

Shared origin

Mechanical-valve thrombogenic conditions

Both motivate long-term anticoagulation

Slide 19 · Thrombotic occlusion: The obstructive sequence

Valve-surface thrombus

Deposit forms on mechanical device

Occlusion

Available flow pathway narrows

Functional stenosis

Resistance to forward flow increases

Hemodynamic burden

Pressure effects depend on valve position

SCHEMATIC — causal / functional relationships

Slide 20 · Embolization: Injury remote from the prosthesis

Valve-associated thrombus

Forms under abnormal flow

Fragment detaches

Embolic material enters circulation

Downstream lodging

Occlusion at a distant site

Clinical consequence

Thromboembolic organ injury

SCHEMATIC — causal / functional relationships

Slide 21 · Mechanical-valve thrombosis: The source figure

Conceptual schematic — thrombus at the valve

Robbins Figure 12.27A depicts thrombosis of a mechanical prosthetic valve.

The morphologic point is thrombotic material involving an artificial valve, not native-leaflet calcification.

The chapter describes device occlusion and valve-derived emboli as separate possible consequences.

The published image illustrates valve-associated thrombosis; The teaching distinction is occlusion versus embolization.

Slide 22 · Why chronic anticoagulation is required

Mechanical prosthesis

Persistent nonlaminar-flow substrate

Ongoing thrombosis risk

Occlusion or embolization

Long-term anticoagulation

Reduces the thrombotic hazard

Trade-off

Greater risk of serious bleeding

SCHEMATIC — causal / functional relationships

Slide 23 · The anticoagulation trade-off is intrinsic

Without adequate thrombotic protection

With anticoagulation exposure

Valve-associated thrombus remains a major concern

Thrombotic risk is addressed but not cost-free

Prosthesis may become occluded

Serious hemorrhage becomes possible

Thrombus may embolize

Hemorrhagic stroke is a specific major concern

Slide 24 · Hemorrhagic stroke is a serious treatment liability

The long-term anticoagulation necessitated by mechanical valves carries bleeding hazards.

Hemorrhagic stroke among the serious consequences.

Other forms of serious bleeding also contribute to prosthesis-related morbidity.

Bleeding is a treatment-associated complication, not mechanical structural failure.

Device benefit ≠ absence of treatment risk

Slide 25 · Assess the mechanism—not just the adverse event

Observation

Mechanistic classification

What it does not prove

Occluded mechanical valve

Local prosthetic thrombosis is a consideration

Not automatically structural fracture

Embolic event

Valve-related thromboembolism is possible

Not proof of infection without evidence

Serious hemorrhage

Anticoagulation-related complication is possible

Not evidence of thrombotic occlusion

Slide 26 · Mechanical structural breakage is uncommon

Current mechanical valves rarely fail from structural deterioration.

The predominant liabilities discussed by Robbins are thrombosis and hemorrhage.

Material durability therefore should not be equated with freedom from complications.

An abnormal mechanical valve should be assessed by the type of dysfunction present.

Structural durability ≠ clinical invulnerability

Slide 27 · Bioprosthetic tissue is nonviable

Processed tissue leaflet

Human cadaveric or animal origin

Nonviable tissue

No living reparative capability

Long-term tissue injury

Calcification and degeneration

Structural failure

Stiffening and/or tearing

SCHEMATIC — causal / functional relationships

Slide 28 · Bioprosthetic calcification alters leaflet function

Progressive calcium deposition

Degeneration within tissue cusps

Leaflet becomes less compliant

Flexibility is lost

Opening or closure may deteriorate

Impaired prosthetic mechanics

Valve dysfunction

Stenotic and/or incompetent behavior

SCHEMATIC — causal / functional relationships

Slide 29 · Bioprosthetic tearing is a structural lesion

Nonviable tissue leaflet

Degenerative material

Tearing

Loss of cusp continuity

Coaptation can fail

Valve no longer closes normally

Incompetence

Regurgitant flow can develop

SCHEMATIC — causal / functional relationships

Slide 30 · Calcification and tearing can coexist

Failure of bioprostheses through calcification and/or tearing.

Figure 12.27B specifically shows a porcine bioprosthesis with calcification and secondary tearing.

The two lesions are not mutually exclusive causes of failure.

A combined structural lesion can compromise leaflet mobility and integrity.

Fig. 12.27B: Calcification with secondary tearing

Slide 31 · From cusp degeneration to incompetence

Bioprosthetic cusp injury

Calcification or tearing

Valve movement fails

Opening or closure compromised

Prosthetic dysfunction

Incompetence; Possibly outflow obstruction

Cardiac burden

Stenotic or regurgitant physiology

SCHEMATIC — causal / functional relationships

Slide 32 · Late failure: Mechanical and tissue valves differ

Mechanism

Mechanical prosthesis

Bioprosthesis

Structural degeneration

Rare with current devices

Expected long-term vulnerability

Characteristic morphologic lesion

Thrombus shown in Fig. 12.27A

Calcium and leaflet tear in Fig. 12.27B

Major clinical consequence

Obstruction or embolus; bleeding under anticoagulation

Failure of valve competence

Shared hazard

Endocarditis possible

Endocarditis possible

Slide 33 · Infection may target two prosthetic compartments

Prosthesis–tissue interface

Vegetations frequently develop where prosthesis joins host tissue.

Extension can produce an annular / ring abscess.

A ring abscess may progress to a paravalvular leak.

Bioprosthetic cusps

Vegetations can involve the tissue leaflets themselves.

Direct leaflet infection adds tissue destruction.

The device may become incompetent through cusp involvement.

Slide 34 · All valve replacements are susceptible to endocarditis

Prosthetic-valve endocarditis is a serious complication of either valve type.

Increased endocarditis risk in prosthetic valves compared with native valves.

Infected vegetations are distinguished from sterile thrombotic deposits by their microbial nature.

The anatomic distribution of infection helps explain subsequent destruction and leakage.

Slide 35 · Bacteremia is the gateway to endocarditis

Microorganisms enter bloodstream

Bacteremia or fungemia

Valve / device seeding

Abnormal or prosthetic surface is vulnerable

Infected vegetation

Thrombotic debris with organisms

Tissue destruction

Abscess, leak, or embolization

SCHEMATIC — causal / functional relationships

Slide 36 · Early prosthetic endocarditis: Source-based pattern

Time context

Organisms emphasized in Robbins

Interpretation

First 1–2 months after surgical implantation

Staphylococcus aureus; Staphylococcus epidermidis

Skin flora are typical in this early setting

Not a universal rule

Other organisms are not logically excluded

Timing informs suspicion; it is not proof

Slide 37 · Late prosthetic endocarditis: A different pattern

Time context

Organisms emphasized in Robbins

Interpretation

At least 1 year after surgery

Streptococci; Staphylococcus aureus

Later microbiologic distribution differs from early cases

Between early and late windows

Not specifically categorized in the excerpt

Do not invent an intermediate-organism rule

Slide 38 · Microbiologic patterns are conditional, not diagnostic

Timing associations describe organisms that are typical—not organisms that must be present.

Culture-negative endocarditis can follow prior antibiotic exposure or difficulty recovering microbes.

Histology or culture of a vegetation or explanted prosthesis may provide pathologic evidence.

Do not label a prosthetic mass infectious from device type or time since surgery alone.

Slide 39 · Vegetations favor the prosthesis–tissue interface

Implanted valve

Synthetic structure joins native tissue

Prosthesis–tissue junction

Common site for vegetation

Infection extends locally

Annular tissue may be invaded

Ring abscess

Destructive periannular complication

SCHEMATIC — causal / functional relationships

Slide 40 · Ring abscess indicates extension beyond a vegetation

A vegetation is infected material attached to an endocardial or valvular surface.

At the prosthetic sewing interface, infection may penetrate adjacent tissue.

Formation of an annular, or ring, abscess.

This is destructive infection of supporting tissue—not merely a mass on the prosthesis.

Vegetation → periannular invasion → ring abscess

Slide 41 · From ring abscess to paravalvular regurgitation

Schematic — infected annulus / paravalvular pathway

Prosthetic vegetation

At tissue interface

Ring abscess

Periannular destruction

Loss of intact seal

Blood can traverse surrounding gap

Paravalvular leak

Regurgitation outside the intended orifice

Slide 42 · Bioprosthetic cusps can be directly infected

The tissue of a bioprosthetic leaflet can carry an infective vegetation.

This contrasts with the frequent prosthesis–tissue-interface distribution described for prosthetic endocarditis.

Cusp involvement and periannular infection are anatomical patterns, not separate microbial diseases.

Each pattern may adversely affect valve function through a different structural route.

Slide 43 · What an infected vegetation contains

Component

Role in pathologic identification

Fibrin and thrombotic debris

Forms part of the vegetation mass

Inflammatory cells

Marks inflammatory response to infection

Bacteria or other microorganisms

Distinguishes microbial vegetation from bland thrombus

Potential adjacent destruction

Supports tissue-invasive endocarditis

Slide 44 · Infected vegetations may embolize

Friable infected vegetation

Organisms within thrombotic mass

Fragment breaks away

Septic embolization

Embolus lodges distally

Downstream vascular obstruction

Secondary infection

Septic infarct or abscess can occur

SCHEMATIC — causal / functional relationships

Slide 45 · Diagnostic evidence for prosthetic endocarditis

Source-supported evidence

What it contributes

Microbiology or tissue demonstration of organism

Supports pathologic/microbiologic infection

Imaging of oscillating mass, abscess or prosthesis separation

Suggests valve/device involvement

New regurgitation on imaging

Indicates new functional damage

Predisposing prosthesis, fever, vascular findings

Contributes to clinical criteria; not diagnostic alone

Slide 46 · 2023 Duke-ISCVID framework

The chapter reproduces a 2023 modified Duke-ISCVID diagnostic criteria table.

Clinical classification requires 2 major criteria, or 1 major plus 3 minor, or 5 minor criteria in the cited table.

Prosthetic valve presence is a minor predisposing factor; It is not independently proof of infection.

Pathologic demonstration of microorganisms in explanted prosthetic tissue is a distinct route of confirmation.

Source: Robbins Table 12.9; 2023 criteria

Slide 47 · Prosthetic endocarditis is harder to eradicate

The cure rate of endocarditis on prosthetic valves is worse than for native-valve infections.

Valve re-replacement is commonly required account.

Periannular infection and abscess provide a structural explanation for the difficulty.

These are clinicopathologic observations—not a current treatment algorithm or indication list.

Slide 48 · Paravalvular leak has more than one cause

Pathway

Tissue-level mechanism

Distinguishing context

Infectious

Ring abscess damages periannular supporting tissue

Prosthetic endocarditis

Noninfectious

Inadequate healing leaves an imperfect seal

Healing-related prosthesis–tissue interface failure

Shared result

Blood bypasses the intended sealed boundary

Paravalvular regurgitation

Slide 49 · Inadequate healing can cause a paravalvular leak

Valve implanted

Prosthesis sits against host tissue

Healing is incomplete

Interface does not become fully sealed

Periprosthetic gap

Blood tracks beside device

Regurgitant leak

Flow through paravalvular pathway

SCHEMATIC — causal / functional relationships

Slide 50 · Fibrous tissue overgrowth can obstruct the valve

Post-implant healing

Fibrous response develops

Excess tissue overgrowth

Tissue projects toward flow path

Reduced effective opening

Prosthetic obstruction

Functional stenosis

Resistance to flow increases

SCHEMATIC — causal / functional relationships

Slide 51 · Valve–orifice disproportion is relative stenosis

Prosthesis effective area

Small for the individual patient

Flow requirement

Patient demands greater throughput

Orifice disproportion

Relative obstruction despite an implanted valve

Functional consequence

Stenotic physiology

SCHEMATIC — causal / functional relationships

Slide 52 · Obstruction has multiple distinct substrates

Source of obstruction

Physical / functional substrate

Category

Mechanical-valve thrombus

Blood clot physically occludes flow path

Thrombotic

Fibrous overgrowth

Healing tissue narrows the orifice

Healing-related

Valve–orifice disproportion

Effective orifice too small for patient needs

Geometric / hemodynamic

Calcified tissue leaflets

Degeneration reduces mobility

Structural degeneration

Slide 53 · Obstruction produces pressure-overload physiology

Reduced effective orifice

Valve obstruction

Higher resistance to ejection

Increased upstream pressure burden

Myocardial adaptation

Pressure-overload hypertrophy can develop

Potential outcome

Decompensation / heart failure

SCHEMATIC — causal / functional relationships

Slide 54 · Intravascular hemolysis reflects high shear

Narrow jet → elevated shear stress

Schematic — red-cell injury in abnormal flow; Not specimen morphology

Abnormal flow channel

Narrow or regurgitant path

High-velocity jet

Elevated shear stress

Red cell injury

Mechanical disruption of erythrocytes

Intravascular hemolysis

Blood destruction within circulation

Slide 55 · Jet injury links valve dysfunction and hemolysis

Intravascular hemolysis caused by high shear forces as a prosthetic-valve complication.

In its parent discussion, a narrowed valve can generate a high-speed blood jet.

A high-velocity jet may also injure endocardium where it strikes.

Hemolysis therefore points to flow-related mechanical injury, not necessarily infection.

Slide 56 · Mechanism-to-manifestation matrix

Mechanism

Valve / tissue consequence

Systemic or clinical consequence

Thrombus on mechanical valve

Occlusion

Embolization may occur

Bioprosthetic degeneration

Calcification and/or tearing

Valve incompetence

Prosthetic infection

Vegetation ± ring abscess

Leak, embolic infection

Interface / flow problems

Leak, overgrowth or mismatch

Regurgitation, stenosis, hemolysis

Slide 57 · Failure pathways differ in timing and substrate

Process

Core substrate

Time statement justified by source

Implant/healing-related

Poor seal; fibrous overgrowth

Associated with healing; exact time not quantified

Mechanical thromboembolism

Disturbed flow

Long-term hazard warranting ongoing anticoagulation

Bioprosthetic degeneration

Nonviable tissue

Long-term calcification or tearing

Endocarditis

Microbial vegetation

Can occur after any valve replacement

Slide 58 · Case 1: An obstructed mechanical prosthesis

A patient with a mechanical valve develops evidence of reduced prosthetic forward flow. A mass is identified at the valve. Which mechanism should be examined first, and what two outcomes can it produce?

Features to interpret

Clue: Mechanical device

Clue: Flow-path obstruction

Distinguish material failure from blood-derived obstruction

Slide 59 · Case 1: Mechanistic interpretation

A mechanical-valve thrombus can produce direct prosthetic occlusion.

The same valve-associated thrombotic process may release emboli into the circulation.

Nonlaminar flow with turbulence and stasis explains the substrate.

The anticoagulation requirement reflects ongoing thromboembolic risk.

Slide 60 · Case 2: A degenerating tissue prosthesis

An explanted porcine bioprosthesis has hard deposits in the cusps and a leaflet tear. Which source-described failure mode links these observations to valve incompetence?

Features to interpret

Clue: Bioprosthetic leaflet tissue

Clue: Calcification plus loss of continuity

Use the textbook Figure 12.27B description

Slide 61 · Case 2: Mechanistic interpretation

Calcification and tearing are the characteristic structural degenerative lesions of bioprostheses.

Robbins specifically describes calcification with secondary tearing in a porcine valve.

Degenerated cusps can lose their capacity for normal opening and closure.

This is a material/tissue failure rather than the typical mechanical-valve thrombosis pathway.

Slide 62 · Case 3: Infected prosthetic annulus

A prosthetic valve has a vegetation at its tissue interface, a periannular abscess, and new leakage around the device. Trace the causal sequence and name the alternative noninfectious cause of a similar leak.

Features to interpret

Clue: Vegetation at the prosthesis–tissue interface

Clue: Annular tissue destruction

Clue: Paravalvular rather than transvalvular leak

Slide 63 · Case 3: Mechanistic interpretation

Infective vegetation may extend into periannular tissue and form a ring abscess.

Destruction of the prosthesis–tissue seal permits a paravalvular regurgitant leak.

Inadequate healing at the prosthesis–tissue interface is a separate, noninfectious cause.

Microbiologic and other clinical evidence distinguishes infective disease from noninfective dehiscence.

Slide 64 · A structured framework for an abnormal prosthesis

Question

Potential explanation

Next interpretive distinction

Obstructed?

Thrombus; overgrowth; disproportion; degenerated cusps

Which substrate compromises effective area?

Regurgitant?

Torn cusp or paravalvular gap

Through prosthesis or around it?

Infected?

Vegetation; abscess; microbial evidence

Infective versus sterile thrombus

Systemic injury?

Emboli, bleeding, or shear-related hemolysis

Device-related versus treatment-related

Slide 65 · Pathology-oriented description of explanted valves

Record

Why it matters

Prosthesis type and involved material

Sets expected dominant failure mechanisms

Thrombus or vegetation; site of attachment

Separates thrombosis from possible infection

Calcification, tear, or fibrous overgrowth

Describes structural or healing-related obstruction

Prosthesis–tissue interface and abscess

Accounts for paravalvular leakage

Correlate with microbiology and clinical findings

Avoids attributing infection from gross appearance alone

Slide 66 · Mechanism summary: A valve can fail in many ways

Major group

Archetypal lesion

Principal teaching distinction

Mechanical thromboembolism

Valve-associated clot

Obstruction versus embolization

Bioprosthetic degeneration

Calcification / tearing

Nonviable tissue deteriorates

Infection

Vegetation / ring abscess

Periannular leak and destructive disease

Other

Inadequate healing, overgrowth, mismatch, shear

Leak, stenosis, hemolysis without fracture

Slide 67 · Essential points for clinical–pathologic reasoning

First identify mechanical versus bioprosthetic construction; Dominant risks differ.

For mechanical valves, link nonlaminar flow to clotting, emboli and the bleeding cost of anticoagulation.

For tissue valves, connect calcification and tearing with structural failure.

For either valve, investigate infection, prosthesis–tissue interface integrity, obstruction and high-shear hemolysis.

Slide 68 · References

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Chapter 12, “The Heart.”

Primary subsection: “Complications of Prosthetic Valves,” pp. 514–515; Figure 12.27 caption, p. 516.

Parent context: “Valvular Heart Disease,” pp. 505–506; “Infective Endocarditis,” pp. 511–513; Table 12.9.

The source discussion and figure descriptions frame the mechanisms reviewed in this lecture.